Infectious Disease
COVID
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
COVID is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed4 · 44%
Recruiting2 · 22%
Withdrawn2 · 22%
Suspended1 · 11%
Clinical Trials
Trial Activity
9 trials
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)
Completed·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Phase 1·NCT04409925·15 enrolled
COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT05518487·15 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)